Microcirculation dysfunction and cardioprotection in cardiac surgery with cardiopulmonary bypass: mechanisms, monitoring, and therapeutic strategies - Scorecard - MDSpire
Advertisement
Microcirculation dysfunction and cardioprotection in cardiac surgery with cardiopulmonary bypass: mechanisms, monitoring, and therapeutic strategies
Clinical Scorecard: Dysfunction of Microcirculation and Cardiac Protection During Cardiac Surgery with Cardiopulmonary Bypass: Mechanisms, Assessment, and Treatment Approaches
CPB disrupts capillary perfusion despite normal systemic hemodynamics
Microcirculatory assessment tools include imaging and circulating biomarkers
Cardioprotective strategies aim to preserve microcirculatory function, including ischemic preconditioning and glycocalyx-preserving therapies
Clinical evidence for interventions remains heterogeneous and inconclusive, particularly regarding specific pharmacologic agents
Gaps exist in translating experimental findings to clinical practice
Guideline-Based Recommendations
Diagnosis
Management
Implement cardioprotective strategies during CPB, including ischemic preconditioning and glycocalyx-preserving therapies
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Pharmacologic interventions include volatile anesthetics, nitric oxide, statins, antioxidants, and antithrombotic agents, which help mitigate microcirculatory dysfunction.
Clinical Best Practices
Focus on optimizing microcirculation during CPB
Integrate bedside imaging techniques such as orthogonal polarization spectral imaging and biomarkers with biophysiological principles